» Articles » PMID: 9069263

AP-1 Function and Regulation

Overview
Publisher Elsevier
Specialty Cell Biology
Date 1997 Apr 1
PMID 9069263
Citations 741
Authors
Affiliations
Soon will be listed here.
Abstract

AP-1 (activating protein-1) is a collective term referring to dimeric transcription factors composed of Jun, Fos or ATF (activating transcription factor) subunits that bind to a common DNA site, the AP-1-binding site. As the complexity of our knowledge of AP-1 factors has increased, our understanding of their physiological function has decreased. This trend, however, is beginning to be reversed due to the recent studies of gene-knockout mice and cell lines deficient in specific AP-1 components. Such studies suggest that different AP-1 factors may regulate different target genes and thus execute distinct biological functions. Also, the involvement of AP-1 factors in functions such as cell proliferation and survival has been made somewhat clearer as a result of such studies. In addition, there has been considerable progress in understanding some of the mechanisms and signaling pathways involved in the regulation of AP-1 activity. In addition to regulation by heterodimerization between Jun, Fos and ATF proteins, AP-1 activity is regulated through interactions with specific protein kinases and a variety of transcriptional coactivators.

Citing Articles

Nitroxidative Stress, Cell-Signaling Pathways, and Manganese Porphyrins: Therapeutic Potential in Neuropathic Pain.

Silva A, de Lavor M Int J Mol Sci. 2025; 26(5).

PMID: 40076672 PMC: 11900433. DOI: 10.3390/ijms26052050.


CTCF/RAD21 organize the ground state of chromatin-nuclear speckle association.

Yu R, Roseman S, Siegenfeld A, Gardner Z, Nguyen S, Tran K Nat Struct Mol Biol. 2025; .

PMID: 39984730 DOI: 10.1038/s41594-024-01465-6.


Exploring the mechanism of action of Lobetyolin in the treatment of allergic rhinitis based on network pharmacology and molecular docking.

Hou L, Yang J, Li Y, Kang J, Ma Z, Luo X Medicine (Baltimore). 2025; 104(7):e41496.

PMID: 39960917 PMC: 11835136. DOI: 10.1097/MD.0000000000041496.


Proteomic meta-analysis unveils new frontiers for biomarkers research in pancreatic carcinoma.

Di Marco F, Cufaro M, Damiani V, Dufrusine B, Pizzinato E, Di Ferdinando F Oncogenesis. 2025; 14(1):3.

PMID: 39956821 PMC: 11830788. DOI: 10.1038/s41389-025-00547-4.


Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status.

Hu C, Chen Y, Yin X, Xu R, Yin C, Wang C Signal Transduct Target Ther. 2025; 10(1):39.

PMID: 39948335 PMC: 11825823. DOI: 10.1038/s41392-024-02098-3.